OptimizeRx (OPRX) Depreciation & Amortization (CF) (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 2.74% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 1.38% YoY), and the FY2025 full-year result was $4.3 million, changed 0.05% from the prior year.
• Depreciation & Amortization (CF) declined to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q3 2024 to a low of $456545.0 in Q4 2022.
• A 5-year average of $832001.7 and a median of $1.1 million in 2026 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) retreated 19.57% in 2023 and soared 134.48% in 2024, its largest moves.
• Tracing OPRX's Depreciation & Amortization (CF) over 5 years: stood at $456545.0 in 2022, then jumped by 120.57% to $1.0 million in 2023, then gained by 8.64% to $1.1 million in 2024, then dropped by 1.46% to $1.1 million in 2025, then decreased by 1.3% to $1.1 million in 2026.
• Business Quant data shows OPRX's Depreciation & Amortization (CF) at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.